SPharm will be attending the 15th Annual Market Access Summit “Engage directly with Regulators, Public & Private Payers, Employers & Patient Groups”, in Toronto on 16 and 17 November, to discuss challenges and changes in drugs market access and to obtain the most up-to-date information for optimizing our client’s reimbursement strategies and improve their submission success.
With over 20 years of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.
Après plus de 20 ans de résultats et de succès constants, SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.